Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients. - Wikidata - wikimedia - TriplyDB

Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.

Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.

http://www.wikidata.org/entity/Q44132305

about

MicroRNAS in endometrial cancer: recent advances and potential clinical applications Guidelines for the design, analysis and interpretation of 'omics' data: focus on human endometrium Impact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological Cancer MiR-410 is overexpressed in liver and colorectal tumors and enhances tumor cell growth by silencing FHL1 via a direct/indirect mechanism The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy Prognostic Role of the MicroRNA-200 Family in Various Carcinomas: A Systematic Review and Meta-Analysis Large oncosomes mediate intercellular transfer of functional microRNA.Integrated miRNA-mRNA analysis revealing the potential roles of miRNAs in chordomas.miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.Circulating MicroRNAs in gynecological malignancies: from detection to prediction Verification of microRNA expression in human endometrial adenocarcinoma.Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers.High-throughput sequencing approach uncovers the miRNome of peritoneal endometriotic lesions and adjacent healthy tissues MicroRNA expression in human endometrial adenocarcinoma A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells miREC: a database of miRNAs involved in the development of endometrial cancer.Prognostic role of miR-200c in various malignancies: a systematic review and meta-analysis.The expression and clinical significance of serum miR-205 for breast cancer and its role in detection of human cancers.miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas.MicroRNA Expression Profile in Penile Cancer Revealed by Next-Generation Small RNA Sequencing.MicroRNA-200 Family Profile: A Promising Ancillary Tool for Accurate Cancer Diagnosis Prognostic and Clinical Significance of miRNA-205 in Endometrioid Endometrial Cancer.In vitro and in vivo activity of miR-92a-Locked Nucleic Acid (LNA)-Inhibitor against endometrial cancer.Candidate biomarkers for genetic and clinicopathological diagnosis of endometrial cancer MicroRNA-340 Inhibits Tumor Cell Proliferation and Induces Apoptosis in Endometrial Carcinoma Cell Line RL 95-2.Circulating microRNAs predict biochemical recurrence in prostate cancer patients.Prognostic significance of miR-194 in endometrial cancer.Overexpression of microRNA-205 predicts lymph node metastasis and indicates an unfavorable prognosis in endometrial cancer.Locked nucleic acid-inhibitor of miR-205 decreases endometrial cancer cells proliferation in vitro and in vivo.Assessment of differentially expressed plasma microRNAs in nonsyndromic cleft palate and nonsyndromic cleft lip with cleft palate.Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.The future therapy of endometrial cancer: microRNA's functionality, capability, and putative clinical application.MiR-200a is involved in proliferation and apoptosis in the human endometrial adenocarcinoma cell line HEC-1B by targeting the tumor suppressor PTEN.Entangling Relation of Micro RNA-let7, miRNA-200 and miRNA-125 with Various Cancers.Circulating microRNAs and extracellular vesicles as potential cancer biomarkers: a systematic review.Epigenetics in endometrial carcinogenesis - part 2: histone modifications, chromatin remodeling and noncoding RNAs.MicroRNAs in gynecological cancers: Small molecules with big implications.Absent MicroRNAs in Different Tissues of Patients with Acquired Cardiomyopathy Identification of microRNA expression profile related to lymph node status in women with early-stage grade 1-2 endometrial cancer.Identification of long non-coding RNAs biomarkers associated with progression of endometrial carcinoma and patient outcomes.

P2860

Q26780358-ADF95F4C-B9FB-49FA-88CE-91E536E40F44 Q27012789-6FF17E6B-018F-4E97-9733-DA7BF0FD0D94 Q27016123-1E2242C0-A385-4736-840E-CC33EDABE9AA Q27342777-D9D90AEB-1026-4DE4-94B4-41378EBE8BDD Q28083742-94E7FDA4-F7E3-4B16-9897-3813E0DC1284 Q30235175-43D8314D-74EC-470F-A863-5AB204E28F33 Q30570006-89AAE423-94A5-4FF0-BEE9-639C9842BC24 Q33274852-C7715974-5641-44C8-99FE-5B5DE62DD7D8 Q33709560-2DE562A2-30A5-432C-BC83-E1FF833874A1 Q33718986-9203C6D0-F9C3-4603-8B6B-6598CFEA5825 Q33816414-4D4A2755-137D-4E5D-9777-E2D3F158E5D1 Q34346375-1840CD7A-B3C7-473D-B211-9EFFEBB823E8 Q34489328-7B9B0CA1-E368-49B1-B785-F10DF938801E Q34558443-52B3D78B-4CD3-470A-BE9D-A2EB5132F4D3 Q35062900-BACB3E5C-E00B-449A-9DF2-C72D6F197021 Q35247692-E8A02D05-93A5-40EA-8EC5-B4609F37A58E Q35479630-A593A22A-15D3-4456-80FE-6E1B524145C9 Q35482100-A1D14AD2-0BFF-44B9-BF1E-B476C064B5FF Q35632200-73C11E0F-AA13-4CE0-A796-22F67661302D Q35687197-46338EFA-91E8-4052-B081-ED766BB37D8A Q35855574-C18A2D3A-9023-4A56-9A6D-8320B5B3CBBC Q36162978-79AE5E08-D8E8-4F3B-B2E0-90DF8116F4A4 Q36174701-0F2379BC-A28B-4C04-9BAC-8C42E8C1A300 Q37007297-CD3AAF79-1AEB-4007-A59E-2D564177508B Q37029456-66D68AA2-ED13-4410-8313-54EE72B5DAD4 Q37081843-A608072A-BD7A-4555-9973-A3CF93B42B28 Q37169644-FB4ED1BC-41CC-4AAB-83F2-8B2442C93AA8 Q37582086-70BBBA03-DAA8-4BCD-9E61-8E614B0B13E1 Q37687451-A4AB15DC-2E3A-47A9-9B5E-C5B764B02BDF Q37699227-43180677-3713-4422-A61A-C265CB49B8A2 Q38258014-C56318EC-F22A-4D84-8361-D1EDCB87CA2B Q38820391-11ED0032-3D6E-4409-9486-DE88ACBE9ED7 Q39035242-8B1467F9-B90E-473D-8595-2CEDD7AA2AE4 Q39077807-057A3E27-F357-4C4C-9159-81E9749F3D4A Q39154029-F714546A-9F4D-4520-AE14-E8FC07E7271F Q39317584-F0FE33E6-8944-4E70-9508-2C96A8ED387B Q39333266-0D6E511A-B291-4A97-88F7-EBC474E589D1 Q39542328-33B9C592-39A6-4FFD-9D70-6781A4D8AF6E Q40928879-4F42BA40-8763-4730-9F35-B266EC1C5FDA Q41592814-87245467-A1FE-485D-B569-D2BC890D3D5C

P2860

Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.

http://www.wikidata.org/entity/Q44132305

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Diagnostic and prognostic sign ...... ndometrial carcinoma patients.

@en

Diagnostic and prognostic sign ...... ndometrial carcinoma patients.

@nl

type

label

Diagnostic and prognostic sign ...... ndometrial carcinoma patients.

@en

Diagnostic and prognostic sign ...... ndometrial carcinoma patients.

@nl

prefLabel

Diagnostic and prognostic sign ...... ndometrial carcinoma patients.

@en

Diagnostic and prognostic sign ...... ndometrial carcinoma patients.

@nl

P1433

Q44132305-0369CE9C-C260-4DC3-8F15-15E76D627828

P1476

Q44132305-878A1F5D-CFA2-4B09-9A36-4937A37F7D82

P2093

Q44132305-0323146C-40CE-4C4C-8D31-E79E99D94CB7

Q44132305-342DC959-EE3E-48A9-97E5-7D7BC122DE44

Q44132305-5169DA03-F5D4-4263-8A5B-FA8E6616FDDB

Q44132305-6BDD53F9-9B19-4A9B-9059-71A2A4AC4470

Q44132305-90D28829-AF3A-4B69-A652-49B5E8AE0596

Q44132305-D34A17EA-0B82-417F-A188-0EEB6DD15D5B

P2860

Q44132305-0141C9C1-7A0A-4DCD-A3CD-2276DFA21F48

Q44132305-03600FFD-95B9-4746-906A-B9597127D115

Q44132305-0899E8F5-1477-45C0-A9E8-43040CD4FA4E

Q44132305-0C5DFCA9-A3D8-4F96-B100-0DA215E593FE

Q44132305-1B12B492-9AA3-4D03-B42B-475E9BDB8C60

Q44132305-201EACB3-1482-4191-84F1-0D4165A280E5

Q44132305-283235D2-9653-428A-B30D-A9B27C44ACAE

Q44132305-2CEF2163-FDC9-40EA-8EF7-7008C58BD698

Q44132305-2E89B1E4-69A6-4E3E-A04F-1B2B59160F22

Q44132305-303BCE69-9EDB-49CC-979F-B3D1F1E5F518

P304

Q44132305-C15FAB73-B7A3-44E8-B0DF-0847861EEB06

P31

Q44132305-FFFFB45F-9B34-4314-BD3E-1583A66FA024

P356

Q44132305-85E4EB1C-847F-4CF1-9B91-7F3B6B9B5F97

P433

Q44132305-F20B18BC-BEF9-4EEE-8BA4-18BEFEE78040

P478

Q44132305-26F0AE17-0559-400C-A4FE-24AA5A51F1B9

P50

Q44132305-C39D1686-555C-496E-81E9-9077FC726828

Q44132305-C8AA9F2D-1815-4CA9-ADBA-6E4EB4F01251

P577

Q44132305-418B6329-82E5-49E4-9675-6C8331B5D86D

P698

Q44132305-F95F2362-5339-44CE-931C-0733EDBB41F1

P921

Q44132305-431E3B1E-7A6A-4188-B62F-8C75B27749C1

P356

P1433

International Journal of Cancer

P1476

Diagnostic and prognostic sign ...... ndometrial carcinoma patients.

@en

P2093

Anna Pesci

http://www.w3.org/2001/XMLSchema#string

Anna Torres

http://www.w3.org/2001/XMLSchema#string

Marcello Ceccaroni

http://www.w3.org/2001/XMLSchema#string

Paola Cassandrini

http://www.w3.org/2001/XMLSchema#string

Ryszard Maciejewski

http://www.w3.org/2001/XMLSchema#string

Tomasz Paszkowski

http://www.w3.org/2001/XMLSchema#string

P2860

Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients

miRNAs in human cancer

MicroRNA signatures differentiate uterine cancer tumor subtypes

Circulating microRNAs as stable blood-based markers for cancer detection.

Mammalian microRNAs predominantly act to decrease target mRNA levels

Silencing of microRNAs in vivo with 'antagomirs'

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

P304

1633-1645

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.27840

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

132

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Zamboni

P577

2012-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22987275

http://www.w3.org/2001/XMLSchema#string

P921